All News #Library
Biotech
Qnovia Doses 1st Patient In US Trial For RespiRx™ Nicotine Inhaler
07 Jan 2025 //
PR NEWSWIRE
Qnovia Raises $16M For RespiRx™ Nicotine Inhaler Development
10 Dec 2024 //
PR NEWSWIRE

Market Place
Sourcing Support